磷酸改性,phosphorous acid modification
1)phosphorous acid modification磷酸改性
英文短句/例句
1.Prepartion and Catalytic Properties of KIT-1 Mesoporous Molecular Sieve Functionalized with Phosphoric Acid介孔分子筛KIT-1表面磷酸改性及其催化性能
2.Modification of ammonium polyphosphate-Recent Progresses in Polyphosphate Esters Flame Retardants聚磷酸铵的改性—聚磷酸酯的研究进展
3.Modification of Catalyst Supported Phosphotungstic Acid and Characterization of Its Acidic Catalysis Performance固载磷钨酸的改性及其酸催化性能表征
4.Phosphate Surface Modification Technique for ZM5;ZM5镁合金磷酸盐表面改性处理技术
5.CHARACTERISTICS OF PHOSPHATE ADSORPTION ON NATURAL AND MODIFIED ZEOLITES天然及改性沸石对磷酸盐的吸附研究
6.Study on the paper plate macerated by modified amidinourea phosphate fire retardant liquid改性脒基脲磷酸盐阻燃浸渍纸板研究
7.Improvement of Phosphomonoesterase Activity Determination in Red soils红壤磷酸单酯酶活性测定方法的改进
8.Improvement of phase change performances of dibasic sodium phosphate十二水磷酸氢二钠相变性能改进研究
9.Modification of Ce(SO_4)_2 on Phosphosilicate Gels used as Proton Conductors硫酸高铈对磷硅酸盐凝胶质子导体的改性处理
10.Surface Modification of Amorphous Calcium Phosphates by Stearic Acid and Their Stability无定形磷酸钙的硬脂酸表面改性及其改性后的稳定性研究
11.Research on Phosphate Adsorption Ability of Treated Waste Rare Earth Polishing Powder;改性废弃稀土抛光粉对磷酸根的吸附性能研究
12.Superiority of a New Modified Phosphate Casting Binder新型改性磷酸盐无机铸造粘结剂的优越性
13.Surface Modification of Nano-Hydroxyapatite with Stearic Acid硬脂酸改性纳米羟基磷灰石表面性能的研究
14.Effects of quaternary ammonium cationic modification on starch phosphate sizing agents季铵醚化改性对磷酸酯淀粉浆料性能的影响
15.Performances and Applications of Magnesium Phosphate Cement-based Composites modified by Fly Ash粉煤灰改性磷酸镁水泥基材料的性能与应用
16.Properties of asphalts modified with polyphosphoric acid/styrene-butadiene rubber多聚磷酸与丁苯橡胶复配改性沥青的性能
17.Phosphorylated Modification of Chitosan for Biomimetic Synthesis of Bone Regeneration Materials;壳聚糖磷酸化改性仿生构建骨再生材料
18.Experimential Reserch on Removal of Phosphorus in Waste Water with Modified Steel Slag;改性钢渣去除废水中磷酸盐的试验研究
相关短句/例句
modified zirconium phosphate改性磷酸锆
3)modified calcium phosphate改性磷酸钙
4)phosphorelated modifications磷酸化改性
1.This article has introduced the main types and functions of the protein phosphorylation,the identification of the phosphopeptides,the determination of the specific-phosphorylation-site and thephosphorelated modifications of the proteins and reviewed their resea.本文介绍了蛋白质磷酸化修饰的主要类型与功能、磷酸化蛋白质及磷酸化肽的标记和分离与富集、磷酸化肽及磷酸化位点分析以及蛋白质的磷酸化改性等方法,并综述了近年来国内外的主要研究进展。
5)modified zinc phosphate改性磷酸锌
1.On the basis of water-borne alkyd coatings, where nano-complex iron oxide/titanium dioxide anti-rust pigment andmodified zinc phosphate combined with certain proportion were led into, the salt fog resistance of the coatings was promoted.在水性醇酸涂料的基础上,引入纳米复合铁钛粉防锈颜料和改性磷酸锌,并将两者以一定比例搭配,提高了漆膜的耐盐雾性。
6)Phosphate modifier磷酸酯盐改性剂
延伸阅读
磷酸伯喹 ,伯喹,伯氨喹啉,磷酸匹马喹啉,磷酸伯氨喹啉,磷酸伯氨喹药物名称：磷酸伯氨喹英文名：Primaquine别名： 伯氨喹;磷酸伯喹 ,伯喹,伯氨喹啉,磷酸匹马喹啉,磷酸伯氨喹啉,磷酸伯氨喹外文名：Primaquine , Primaquine Phosphate适应症： 为阻止疟疾复发、中断传播的有效药物。现主要用于根治间日疟和控制疟疾传播，常与氯喹或乙胺嘧啶合用。对恶性疟红细胞内期则完全无效，不能作为控制症状的药物应用。对某些疟原虫的红细胞前期也有影响，但因需用剂量较大，已接近极量，不够安全，故也不能作为病因预防药应用。 用量用法： 1.根治间日疟：每日口服２６．４ｍｇ（盐基１５ｍｇ），连服１４日；或每日服３９．６ｍｇ，连服８日。服此药前３日同服氯奎，或在第１、２日同服乙胺嘧啶。 2.控制疟疾传播配合氯喹等治恶性疟时，每日服２６．４ｍｇ，连服３日。 注意事项： 1.本品口服后吸收迅速但消失也快，作用时间不持久，故必须每日给药。 2.毒性比其他抗疟药大。每日剂量超过５２．８ｍｇ时，易发生疲乏、头昏、恶心、呕吐、腹痛、发绀、药热等症状，停药后可自行恢复。 3.少数特异质者可发生急性溶血性贫血（因其红细胞缺乏葡萄糖６－磷酸脱氢酶应即停药，给予地噻米松或泼尼松可缓解，并静滴５％葡萄糖氯化钠注射液，严重者输血。如发生高铁血红蛋白血症，可静注亚甲蓝每千克体重１～２ｍｇ。 4.孕妇忌用，肝、肾、血液系统疾患者及糖尿病病人慎用。 规格： 片剂：每片含磷酸伯氨喹１３．２ｍｇ或２６．４ｍｇ（相当于伯氨喹盐基７．５ｍｇ或１５ｍｇ）。 类别：抗疟药
